Cargando…
Successful treatment with erythromycin for idiopathic thrombocytopenic purpura
Macrolides have both immunomodulatory and antibacterial effects. We report 3 cases of primary immune thrombocytopenia (ITP) patients who were successfully treated with macrolides, irrespective of Helicobacter pylori (H. pylori) infection status. Case 1, an 88-year-old woman who was an H. pylori-posi...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3128896/ https://www.ncbi.nlm.nih.gov/pubmed/21747888 http://dx.doi.org/10.5045/kjh.2011.46.2.139 |
_version_ | 1782207485803757568 |
---|---|
author | Ohe, Masashi Hashino, Satoshi |
author_facet | Ohe, Masashi Hashino, Satoshi |
author_sort | Ohe, Masashi |
collection | PubMed |
description | Macrolides have both immunomodulatory and antibacterial effects. We report 3 cases of primary immune thrombocytopenia (ITP) patients who were successfully treated with macrolides, irrespective of Helicobacter pylori (H. pylori) infection status. Case 1, an 88-year-old woman who was an H. pylori-positive ITP patient, was treated with clarithromycin (CAM). CAM was effective temporarily. As an alternative to CAM, she was successfully treated with erythromycin (EM) for more than 7 months. Case 2, a 61-year-old man who was an H. pylori-negative ITP patient, was unsuccessfully treated with CAM but successfully treated with EM. Case 3, a 75-year-old woman who was a H. pylori-negative ITP patient, was treated with CAM. CAM was effective temporarily. After approximately 6 months, she was treated with EM for a common cold, and her platelet count increased rapidly. Based on these findings, macrolide treatment was effective for ITP. The effectiveness of macrolides might suggest immunomodulatory effects as well as antibacterial effects for H. pylori. |
format | Online Article Text |
id | pubmed-3128896 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis |
record_format | MEDLINE/PubMed |
spelling | pubmed-31288962011-07-11 Successful treatment with erythromycin for idiopathic thrombocytopenic purpura Ohe, Masashi Hashino, Satoshi Korean J Hematol Case Report Macrolides have both immunomodulatory and antibacterial effects. We report 3 cases of primary immune thrombocytopenia (ITP) patients who were successfully treated with macrolides, irrespective of Helicobacter pylori (H. pylori) infection status. Case 1, an 88-year-old woman who was an H. pylori-positive ITP patient, was treated with clarithromycin (CAM). CAM was effective temporarily. As an alternative to CAM, she was successfully treated with erythromycin (EM) for more than 7 months. Case 2, a 61-year-old man who was an H. pylori-negative ITP patient, was unsuccessfully treated with CAM but successfully treated with EM. Case 3, a 75-year-old woman who was a H. pylori-negative ITP patient, was treated with CAM. CAM was effective temporarily. After approximately 6 months, she was treated with EM for a common cold, and her platelet count increased rapidly. Based on these findings, macrolide treatment was effective for ITP. The effectiveness of macrolides might suggest immunomodulatory effects as well as antibacterial effects for H. pylori. Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2011-06 2011-06-21 /pmc/articles/PMC3128896/ /pubmed/21747888 http://dx.doi.org/10.5045/kjh.2011.46.2.139 Text en © 2011 Korean Society of Hematology http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Ohe, Masashi Hashino, Satoshi Successful treatment with erythromycin for idiopathic thrombocytopenic purpura |
title | Successful treatment with erythromycin for idiopathic thrombocytopenic purpura |
title_full | Successful treatment with erythromycin for idiopathic thrombocytopenic purpura |
title_fullStr | Successful treatment with erythromycin for idiopathic thrombocytopenic purpura |
title_full_unstemmed | Successful treatment with erythromycin for idiopathic thrombocytopenic purpura |
title_short | Successful treatment with erythromycin for idiopathic thrombocytopenic purpura |
title_sort | successful treatment with erythromycin for idiopathic thrombocytopenic purpura |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3128896/ https://www.ncbi.nlm.nih.gov/pubmed/21747888 http://dx.doi.org/10.5045/kjh.2011.46.2.139 |
work_keys_str_mv | AT ohemasashi successfultreatmentwitherythromycinforidiopathicthrombocytopenicpurpura AT hashinosatoshi successfultreatmentwitherythromycinforidiopathicthrombocytopenicpurpura |